These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Role of endothelin-1 and nitric oxide bioavailability in transplant-related vascular injury: comparative effects of rapamycin and cyclosporine. Ramzy D; Rao V; Tumiati LC; Xu N; Miriuka S; Delgado D; Ross HJ Circulation; 2006 Jul; 114(1 Suppl):I214-9. PubMed ID: 16820575 [TBL] [Abstract][Full Text] [Related]
28. Sirolimus attenuates chronic allograft nephropathy in an experimental rat kidney transplantation model. Savikko J; von Willebrand E Transplant Proc; 2006 Oct; 38(8):2699-700. PubMed ID: 17098043 [TBL] [Abstract][Full Text] [Related]
29. [Rapamycin and lymphangiogenesis: side effect or treatment result?]. Stallone G G Ital Nefrol; 2008; 25(2):157. PubMed ID: 18350493 [No Abstract] [Full Text] [Related]
30. Effects of tacrolimus, cyclosporin A and sirolimus on MG63 cells. Krocker D; Perka C; Tuischer J; Funk J; Tohtz S; Buttgereit F; Matziolis G Transpl Int; 2006 Jul; 19(7):563-9. PubMed ID: 16764635 [TBL] [Abstract][Full Text] [Related]
31. Infectious risk in pediatric organ transplant recipients: is it increased with the new immunosuppressive agents? Renoult E; Buteau C; Lamarre V; Turgeon N; Tapiero B Pediatr Transplant; 2005 Aug; 9(4):470-9. PubMed ID: 16048599 [TBL] [Abstract][Full Text] [Related]
32. Sirolimus in de novo heart transplant recipients with severe renal impairment. Vazquez de Prada JA; Vilchez FG; Cobo M; Ruisanchez C; Valls MF; Ruano J; Piñera C; Duran RM Transpl Int; 2006 Mar; 19(3):245-8. PubMed ID: 16441775 [TBL] [Abstract][Full Text] [Related]
33. Persistent clinical impact of cytomegalovirus in organ transplantation. Snydman DR Clin Infect Dis; 2008 Oct; 47(7):883-4. PubMed ID: 18778227 [No Abstract] [Full Text] [Related]
34. [To stay immature: the first step to tolerate?]. Grosjean F G Ital Nefrol; 2008; 25(4):383. PubMed ID: 18663680 [No Abstract] [Full Text] [Related]
35. Conversion to sirolimus in posttransplant renal neoplasms. Lopez V; Gutierrez C; Cabello M; Burgos D; Sola E; Gonzalez-Molina M Transplant Proc; 2007 Sep; 39(7):2264-6. PubMed ID: 17889158 [TBL] [Abstract][Full Text] [Related]
36. Sirolimus and FK778: a comparison of two anti-proliferative immunosuppressants for prevention of experimental obliterative airway disease. Deuse T; Schrepfer S; Koch-Nolte F; Haddad M; Schäfer H; Detter C; Reichenspurner H Transpl Int; 2006 Apr; 19(4):310-8. PubMed ID: 16573547 [TBL] [Abstract][Full Text] [Related]